- Advertise
- Contact Us
- Editorial Info
- Terms and Conditions
- Privacy Policy
- Do Not Sell My Personal Information
© 2023 MJH Life Sciences™ and Practical Cardiology. All rights reserved.
Cholesterol Disorders
The Practical Cardiology™ Cholesterol Disorders clinical resource center offers the latest information from the field of lipidology. With hypercholesterolemia and hyperlipidemia representing a crucial aspect of risk management, this page will be a hub for information related to the latest in cholesterol management and dyslipidemia, including articles, videos, and podcasts.
Preexisting Statin Use Linked to Lower COVID-19 Severity
October 24, 2022
An analysis of electronic medical record data from more than 140k patients hospitalized at 185 medical centers in the US provides insight into associations between preexisting statin use and reduced risk of severe disease in COVID-19.
Study Details Gaps in Diagnosis for Homozygous Familial Hypercholesterolemia in the US
October 12, 2022
An analysis of the CASCADE FH Registry provides insight into differences in patient characteristics and outcomes among those with homozygous familial hypercholesterolemia enrolled in the registry as children and those enrolled in the registry as adults.
Rethinking Statins: Time for Primordial Prevention?
September 27, 2022
Statins and their specific role have been the subject of debate for years. In this feature, 6 leading experts in cardiometabolic health share their perspectives on whether statins should be used in the sense of primordial prevention for ASCVD.
Network Meta-Analysis Details Comparative Efficacy of Nonstatin Lipid-Lowering Agents
September 23, 2022
A meta-analysis of 48 randomized controlled trials provides clinicians with insight into the comparative efficacy profiles of multiple nonstatin LDL-lowering agents when added to maximally tolerated statin therapy.
Statin Muscle Symptom Risk Overblown, Does Not Outweigh CV Benefits, CTT Study Shows
August 29, 2022
Results of a CTT meta-analysis from ESC Congress 22 detail the excess risk of muscle symptoms observed with statin therapy from more than 20 clinical trials assessing statins against placebo or less intensive statin therapy.
Cardiology Month in Review: August 2022
August 27, 2022
Our cardiology month in review spotlights the most popular content from the past month. The top content from August 2022 includes new antithrombotic guidance from CHEST, USPSTF recommendation statement on statin use in primary prevention, and coverage of ESC 22, including DELIVER, TIME, and other late-breaking data.
Modeling Study Sheds Light on Benefits on Lifelong Statin Therapy
August 25, 2022
A modeling study presented at ESC 2022 provides insight into the differences in potential benefits of statin therapy based on lifelong use, delayed initiation, and early discontinuation among patients across the spectrum of cardiovascular risk.
USPSTF Reaffirms Endorsement for Statin Use in Primary Prevention Settings
August 23, 2022
The USPSTF released a new recommendation statement on August 23 outlining the organization's stance on use of statins for primary prevention based on current available evidence, with recommendations made for those 40-75, 75 and older, and based on 10-year CVD risk.
High HDL-C Could Increase Cardiovascular Disease Risk in Men with Hypertension
August 19, 2022
An analysis of more than 25,000 years of patient data details a U-shaped association between HDL-C levels and cardiovascular risk among adult men with high blood pressure.
Study Warns of Significant Increases in Diabetes and Cardiovascular Disease by 2060
August 01, 2022
Using data from the 2020 US Census report and recent NHANES survey data, investigators from Massachusetts General Hospital detail expected increases in the prevalence of cardiovascular risk factors and cardiovascular disease among the US population by 2060.